USA - engelska - NLM (National Library of Medicine)

first cosmetic co., ltd - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - niacinamide 1.0 g in 50 ml - purpose: skin brightening & anti wrinkle uses: the double-functional cosmetic for wrinkle and whitening contains adenosine and niacinamide which help your skin get moist and healthy with the ingredients of donkey milk full of nutrients. amino acid, marine collagen, egf, acetalhexapeptide and the patented (10-1607503) ice plant callus extract supply nutrients and moisture to your skin, making your skin more elastic. donkey milk

USA - engelska - NLM (National Library of Medicine)

first cosmetic co., ltd - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - niacinamide 0.54 g in 27 g - purpose: skin brightening & anti wrinkle uses: mulbit donkey milk moisturizing mask is the new project created by know-how of beauty experts! it gives highly effective results to your skin as though you have your skin treated by a professional aesthetician. the gentle silky texture of the premium cellulose sheet gives excellent adhesion to your skin and it offers abundant moisture and concentrated nutrition supply as it contains one whole bottle of ample. the double-functional cosmetic for wrinkle and whitening, containing adenosine and niacinamide, improves your skin to be more lively and elastic with donkey milk full of nutrients. the patented (10_160753) ice plant callus extract gives plentiful nutrients to your stimulated skin layer and forms moisture coat, making your skin even moister.

USA - engelska - NLM (National Library of Medicine)

avondale pharmaceuticals, llc - niacin (unii: 2679mf687a) (niacin - unii:2679mf687a) - niacin 500 mg - i. therapy with lipid-altering agents should be only one component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. nicotinic acid, alone or in combination with a bile-acid binding resin, is indicated as an adjunct to diet for the reduction of elevated total and ldl cholesterol levels in patients with primary hypercholesterolemia (types iia and iib)†, when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate (see also the ncep treatment guidelines6 ). prior to initiating therapy with nicotinic acid, secondary causes for hypercholesterolemia (e.g., poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be excluded, and a lipid profile performed to measure total cholesterol, hdl cholesterol, and triglycerides. ii. nicotinic acid is also indicated as adjunctive therapy for the treatment of adult patients with very high serum triglyceride levels (types iv and v hyperlipidemia)† who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. such patients typically have serum triglyceride levels over 2000 mg/dl and have elevations of vldl cholesterol as well as fasting chylomicrons (type v hyperlipidemia)†. subjects who consistently have total serum or plasma triglycerides below 1000 mg/dl are unlikely to develop pancreatitis. therapy with nicotinic acid may be considered for those subjects with triglyceride elevations between 1,000 and 2,000 mg/dl who have a history of pancreatitis or of recurrent abdominal pain typical of pancreatitis. some type iv patients with triglycerides under 1,000 mg/dl may, through dietary or alcoholic indiscretion, convert to a type v pattern with massive triglyceride elevations accompanying fasting chylomicronemia, but the influence of nicotinic acid therapy on the risk of pancreatitis in such situations has not been adequately studied. drug therapy is not indicated for patients with type i hyperlipoproteinemia, who have elevations of chylomicrons and plasma triglycerides, but who have normal levels of vldl. inspection of plasma refrigerated for 14 hours is helpful in distinguishing types i, iv, and v hyperlipoproteinemia7 . nicotinic acid is contraindicated in patients with a known hypersensitivity to any component of this medication; significant or unexplained hepatic dysfunction; active peptic ulcer disease; or arterial bleeding.

USA - engelska - NLM (National Library of Medicine)

mbg inc (korea institute of science development) - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 0.02 mg in 100 ml

USA - engelska - NLM (National Library of Medicine)

mbg inc (korea institute of science development) - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 0.02 mg in 100 ml

USA - engelska - NLM (National Library of Medicine)

mbg inc (korea institute of science development) - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 0.02 mg in 100 ml

USA - engelska - NLM (National Library of Medicine)

mbg inc (korea institute of science development) - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 0.02 mg in 100 ml

USA - engelska - NLM (National Library of Medicine)

mbg inc (korea institute of science development) - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 0.02 g in 100 g

USA - engelska - NLM (National Library of Medicine)

phytos co., ltd. - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz), phytosphingosine (unii: gin46u9q2q) (phytosphingosine - unii:gin46u9q2q) - niacinamide 0.02 in 30 ml

USA - engelska - NLM (National Library of Medicine)

nature republic co., ltd. - niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - niacinamide 2.0 g in 100 ml - purpose: skin brightening indications & usage: this mild cleansing foam helps brighten skin complexion.